Preventive vaccines are targeted at healthy populations and are available to susceptible populations.It refers to the preventive vaccination of the patient before the infection of the pathogen or in the body without the disease.
This report contains market size and forecasts of Preventive Vaccines in global, including the following market information:
Global Preventive Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Preventive Vaccines Market Sales, 2017-2022, 2023-2028, (K Doses)
Global top five Preventive Vaccines companies in 2021 (%)
The global Preventive Vaccines market was valued at 56140 million in 2021 and is projected to reach US$ 97530 million by 2028, at a CAGR of 8.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Intramuscular Injection Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Preventive Vaccines include Sanofi, AstraZeneca, CSL Ltd, Abbott, GlaxoSmithKline and Serum Institute of India, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Preventive Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Preventive Vaccines Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Preventive Vaccines Market Segment Percentages, by Type, 2021 (%)
Intramuscular Injection
Nasal Spray
Intradermal Shot
Global Preventive Vaccines Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Preventive Vaccines Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Other
Global Preventive Vaccines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Doses)
Global Preventive Vaccines Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Preventive Vaccines revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Preventive Vaccines revenues share in global market, 2021 (%)
Key companies Preventive Vaccines sales in global market, 2017-2022 (Estimated), (K Doses)
Key companies Preventive Vaccines sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
AstraZeneca
CSL Ltd
Abbott
GlaxoSmithKline
Serum Institute of India